Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172128 · ClinicalTrials.gov registry record · NA
Effect of Blueberry Supplementation on Alzheimer's Biomarkers
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05172128 is a NA study that has completed, run by Duke University. The registered enrollment target is 12 participants.
The verdict
NCT05172128, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effects of blueberries on neuronal, glial, and pathology blood biomarkers in Mild Cognitive Impairment (MCI) and to estimate sample size for future confirmatory studies. The blood biomarkers to be measured are Neurofilament light (NfL), glial fibrillary acidic protein (GFAP), Aß40, Aß42, p-tau181, and cytokines, using an ultra-sensitive state-of-the-art immunoassay.
Interventions
- DIETARY_SUPPLEMENT lyophilized blueberry supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2023-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172128
The ClinicalTrials.gov registry entry for NCT05172128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lyophilized blueberry supplement is the first listed.
NCT05172128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05172128 about?
NCT05172128 is a clinical study titled "Effect of Blueberry Supplementation on Alzheimer's Biomarkers". The purpose of this study is to study the effects of blueberries on neuronal, glial, and pathology blood biomarkers in Mild Cognitive Impairment (MCI) and to estimate sample size for future confirmatory studies. The blood biomarkers to be measured are Neurofilament light (NfL), glial fibrillary acid...
What is the current status of trial NCT05172128?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-02-21. Estimated completion is 2023-02-06.
What interventions are being tested in trial NCT05172128?
The interventions under investigation include: lyophilized blueberry supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05172128?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.